GREENWICH LIFESCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period
GREENWICH LIFESCIENCES, INC. (GLSI) reported Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period of 120 shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Additional General Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod · last filed 2026-08-11
- GREENWICH LIFESCIENCES, INC. share-based compensation arrangement by share-based payment award, shares issued in period for the quarter ending 2026-06-30 was 0.00 shares.
- GREENWICH LIFESCIENCES, INC. share-based compensation arrangement by share-based payment award, shares issued in period for the quarter ending 2026-03-31 was 120.00 shares, a 0.00% change year-over-year.
- GREENWICH LIFESCIENCES, INC. share-based compensation arrangement by share-based payment award, shares issued in period for the quarter ending 2025-12-31 was 0.00 shares.
- GREENWICH LIFESCIENCES, INC. share-based compensation arrangement by share-based payment award, shares issued in period for the quarter ending 2025-09-30 was 0.00 shares.
- GREENWICH LIFESCIENCES, INC. share-based compensation arrangement by share-based payment award, shares issued in period for fiscal 2025 was 120.00 shares, a 0.00% change from fiscal 2024.
- GREENWICH LIFESCIENCES, INC. share-based compensation arrangement by share-based payment award, shares issued in period for fiscal 2024 was 120.00 shares, a 0.00% change from fiscal 2023.
- GREENWICH LIFESCIENCES, INC. share-based compensation arrangement by share-based payment award, shares issued in period for fiscal 2023 was 120.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | 120.00 shares 10-Q · filed 2026-08-11 | 120.00 shares derived: sum of 3 quarters · filed 2026-08-11 | 120.00 shares derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 120.00 shares 10-Q · filed 2026-06-04 | 120.00 shares derived: sum of 2 quarters · filed 2026-06-04 | 120.00 shares derived: sum of 3 quarters · filed 2026-06-04 | 120.00 shares derived: sum of 4 quarters · filed 2026-06-04 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-01 | 0.00 shares derived: sum of 2 quarters · filed 2026-06-01 | 0.00 shares derived: sum of 3 quarters · filed 2026-06-01 | 120.00 shares 10-K · filed 2026-06-01 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2025-11-14 | 120.00 shares 10-Q · filed 2025-11-14 | 120.00 shares derived: sum of 4 quarters · filed 2025-11-14 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 120.00 shares 10-Q · filed 2025-08-14 | 120.00 shares derived: sum of 3 quarters · filed 2025-08-14 | 120.00 shares derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | 120.00 shares 10-Q · filed 2025-05-20 | 120.00 shares derived: sum of 2 quarters · filed 2025-05-20 | 120.00 shares derived: sum of 3 quarters · filed 2025-05-20 | 120.00 shares derived: sum of 4 quarters · filed 2025-05-20 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | 0.00 shares derived: sum of 2 quarters · filed 2025-04-15 | 0.00 shares derived: sum of 3 quarters · filed 2025-04-15 | 120.00 shares 10-K · filed 2025-04-15 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2024-11-14 | 120.00 shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | 120.00 shares 10-Q · filed 2024-08-14 | ||
| 2024-03-31 | 120.00 shares 10-Q · filed 2024-05-20 | |||
| 2023-12-31 | 120.00 shares 10-K · filed 2024-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |